Dr. Vineet Veitla, MD

Dr. Veitla practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Veitla's NPI, 1508271545, was assigned on June 28, 2014. Dr. Veitla holds Wisconsin license 67244.

Dr. Veitla's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Veitla's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Veitla practices. Vendor and product names are available with a free account.

Nephrology is Dr. Veitla's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Veitla is licensed in Wisconsin.

CMS data shows 423 Medicare services from Dr. Veitla across 8 procedure codes in 2024, for 161 Medicare patients. Medicare paid $43,112 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 161 Medicare patients who saw Dr. Veitla in 2024. The largest group is under 65, with 81 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 47% are also on Medicaid. Their average risk score is 6.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Veitla's median patient age at 62, with 45% women.

In 2017, Dr. Veitla wrote 35 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $287 in total drug cost. In 2016, CMS named 72 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Veitla for performance year 2024, reported as part of a group. Dr. Veitla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Veitla, published from 2014 to 2022. 2015 was the busiest year, with 3. The most frequent topics are Autoantibodies, Enzyme-Linked Immunosorbent Assay and Receptor, Angiotensin, Type 1. Dr. Veitla's most frequent co-authors are Bhavna Bhasin-Chhabra, MD, Abhilash Koratala, MD and Jonathan Trueblood Liles, MD.

CMS Open Payments shows 29 general payments to Dr. Veitla from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. GE Healthcare paid the most, $596.